CD82 and Familial prostate cancer: Recent years studies have demonstrated CD82 as a metastatic suppressor in many malignant solid cancer cell types including prostate cancer [9],bladder cancer [10], breast cancer [11], pancreatic cancer, and hepatocarcinoma [12] cells.